LYSOGENIC HSV VIRUS

Clinical trials for LYSOGENIC HSV VIRUS explained in plain language.

Never miss a new study

Get alerted when new LYSOGENIC HSV VIRUS trials appear

Sign up with your email to follow new studies for LYSOGENIC HSV VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Modified herpes virus joins forces with immunotherapy to attack head and neck tumors

Disease control Ongoing

This study tests a combination of three treatments—immunotherapy (tislelizumab), targeted therapy (afatinib), and a modified herpes virus (lysogenic HSV)—given before surgery for head and neck squamous cell carcinoma. The goal is to see if this approach safely shrinks tumors and …

Matched conditions: LYSOGENIC HSV VIRUS

Phase: PHASE1, PHASE2 • Sponsor: West China Hospital • Aim: Disease control

Last updated Jul 02, 2026 04:00 UTC

LYSOGENIC HSV VIRUS

Get alerted when new LYSOGENIC HSV VIRUS trials appear

Modified herpes virus joins forces with immunotherapy to attack head and neck tumors